Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-30 @ 10:44 PM
Study NCT ID:
NCT02745769
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2016-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-18
First Submit QC Date:
None
Study First Post Date:
2016-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-02
Last Update Post Date:
2019-03-05
Last Update Post Date Type:
ACTUAL